Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
View in:
PubMed
subject areas
Angina Pectoris
Antigens, CD34
Cell- and Tissue-Based Therapy
Double-Blind Method
Exercise Test
Humans
Myocardium
Stem Cells
Transplantation, Autologous
Treatment Outcome
authors with profiles
Robert Harrington